Prelude Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Prelude Capital Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-300	Closed	-$4K	–	2366
2018 Q4	$4K	Buy	+300	New	+$5.06K	﹤0.01%	1663
2016 Q4	–	Sell	-19,200	Closed	-$538K	–	1901
2016 Q3	$538K	Buy	+19,200	New	+$644K	0.06%	297

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Prelude Capital Management's DPLO Position: Q1 2020 in Review

Prelude Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 18,810 shares — an estimated $75K sold.

Prelude Capital Management first reported a position in DPLO in Q4 2015 and held it in 8 quarters. The position peaked at $199K in Q4 2015. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

Prelude Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
Prelude Capital Management sold 18,810 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $75K.
Prelude Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 8 quarters.
Prelude Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $199K in Q4 2015.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Prelude Capital Management's 13F filing for Q1 2020, filed 15 May 2020.